Individual Study / UK Biobank

UK Biobank

UK Biobank

UK Biobank logo
Initiatives -
To improve the prevention, diagnosis, and treatment of a wide range of diseases – including cancer, heart diseases, stroke, diabetes, arthritis, osteoporosis, eye disorders, depression and forms of dementia. **** **Access Management Team:**
Start Year
UK Biobank is funded primarily by the Wellcome charity and the Medical Research Council (MRC). It has also had funding from the Department of Health, Scottish Government, the Northwest Regional Development Agency, the Welsh Government, British Heart Foundation, Cancer Research UK and Diabetes UK. UK Biobank is supported by the National Health Service (NHS).
Supplementary Information
Funding details:
Visit UK Biobank


Investigators Contacts
  • Dr. Naomi Allen
    University of Oxford
  • Prof. Rory Collins
    University of Oxford


Study design
Population cohort
Follow Up
A detailed follow-up of participants over a 20-year period is envisaged through data linkage to national electronic medical records. Thus, linking to NHS will provide valuable information on health outcomes (eg, mortality, cancer registrations, hospital admissions, primary care data, etc).
Supplementary Information

Marker Paper

Chua SYL, Thomas D, Allen N, Lotery A, Desai P, Patel P, Muthy Z, Sudlow C, Peto T, Khaw PT, Foster PJ; UK Biobank Eye & Vision Consortium. Cohort profile: design and methods in the eye and vision consortium of UK Biobank. BMJ Open. 2019 Feb 21;9(2):e025077. doi: 10.1136/bmjopen-2018-025077.

PUBMED 30796124


Sources of Recruitment
  • Individuals

Number of participants

Number of participants
Number of participants with biosamples
Supplementary Information
Aged between 40-69 years from across UK.


Availability of data and biosamples


Availability of access information

On the study website :

Supplementary Information